Pacific Biosciences of California, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Pacific Biosciences of California, Inc. (PACB) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.40% for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2014-03-14
- Pacific Biosciences of California, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 1.40%.
- Pacific Biosciences of California, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 1.40%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-12-31 | 1.40% 10-K · filed 2014-03-14 | |||
| 2013-09-30 | 1.40% 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | 1.40% 10-Q · filed 2013-08-09 | |||
| 2013-03-31 | 1.40% 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |